Search
for
Sort by
Research 571–600 of 1000+
- Recent Advances in Drug Development for Hair Loss
- A systematic review on Drug Re-profiling/Re-Purposing
- Drug repurposing: Clinical practices and regulatory pathways
- Drug-induced vitiligo: a real-world pharmacovigilance analysis of the FAERS database
- Patient Profile and Treatment Characteristics of Adults and Adolescents Prescribed Ritlecitinib for Alopecia Areata in the USA
- KRDQN: An Interpretable Prediction Framework for Adverse Drug Reactions via Knowledge–Graph Reinforced Deep Q-Learning
- Chitosan Nanoparticles for Topical Drug Delivery in Chemotherapy-Induced Alopecia: A Comparative Study of Five Repurposed Pharmacological Agents
- Computational drug discovery of potential 5α-reductase phytochemical inhibitors and hair growth promotion using in silico techniques
- The pharmacovigilance analysis of adverse events of erlotinib based on the open access FAERS database
- Advances and Prospects for Hydrogel-Forming Microneedles in Transdermal Drug Delivery
- Suicidality Risks Associated with Finasteride, a 5-Alpha Reductase Inhibitor: An Evaluation of Real-World Data from the FDA Adverse Event Reports
- Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak
- Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
- Antiviral Drugs Screening for Swine Acute Diarrhea Syndrome Coronavirus
- A Concept on The Development of The DRDE Series of Compounds for Skin Diseases Using In-Silico ADME And Drug-Likeness Analysis
- Incretin-Based Drugs for Obesity: Common and Drug-Specific Reporting Patterns of Adverse Drug Reactions—A Comparative Disproportionality Analysis Using EudraVigilance Reports Integrating SmPC Data
- Advances in Cell-Mediated Drug Delivery for Dermatologic Diseases: Mechanisms and Current Applications
- Repurposing existing drugs for the treatment ofCOVID-19/SARS-CoV-2: A review of pharmacological effects and mechanism of action
- Enhanced ex vivo skin retention of bicalutamide using a nano-in-micro composite: Drug-loaded lipid vesicles in a dissolving microarray patch
- Low‐Dose Oral Minoxidil and Associated Adverse Events: Analyses of the FDA Adverse Event Reporting System (FAERS) With a Focus on Pericardial Effusions
- The pattern of off-label and unlicensed drug use in adult and pediatric patients in the Kingdom of Saudi Arabia: multicenter retrospective study
- Bubble-Based Drug Delivery Systems: Next-Generation Diagnosis to Therapy
- Microneedle Transdermal Drug Delivery Systems for Allergen-Specific Immunotherapy, Skin Disease Treatment, and Vaccine Development
- Physicochemical Characterization of Chitosan-Decorated Finasteride Solid Lipid Nanoparticles for Skin Drug Delivery
- Dissolving microneedles incorporating kopexil multicomponent crystals for improved transdermal delivery
- Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases
- Coming full circle (almost): Low dose oral minoxidil for alopecia
- Modern Polycystic Ovary Syndrome (PCOS) Management: Intelligent Drug Delivery and Metabolic Reprogramming for Ovarian Restoration and Fertility Optimization
- Progress in Topical and Transdermal Drug Delivery Research—Focus on Nanoformulations
- Recent Insights in Multi‐Target Drugs in Pharmacology and Medicinal Chemistry